Home

Nicholas A Saccomano

CIK 1609284 · President and CEO · last filed 2026-09-23

Nicholas A Saccomano is a President and CEO who has filed 26 SEC Form 4 insider transactions across 1 company since 2024. The most recent filing shows the insider sold $259 of OKUR on Sep 23, 2026. Across all open-market trades the lifetime net is −$4.3K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $32.4K across reported positions. 16 SEC filings were submitted jointly with ARRAY BIOPHARMA INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$32.4K

Companies

1

Total Filings

26

Lifetime Open-Market Net

-$4.3K

Filer Profile

Reported Address
3200 WALNUT STREET
BOULDER, CO 80301
Phone
(303) 381-6600
Related Filers
ARRAY BIOPHARMA INC — 16 joint filings, latest 2019-07-30
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
OKUR President and CEO 11,160 $2.90 $32.4K -$4.3K 11 2026-09-23

Recent Filings

26 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-09-23 OKUR Sell (S) −87 -$259 EDGAR
2026-08-11 OKUR Mixed — $0 EDGAR
2026-06-24 OKUR Sell (S) −86 -$378 EDGAR
2026-04-03 OKUR Grant (A) — $0 EDGAR
2026-03-24 OKUR Sell (S) −86 -$357 EDGAR
2025-12-23 OKUR Sell (S) −87 -$258 EDGAR
2025-09-24 OKUR Sell (S) −88 -$231 EDGAR
2025-06-25 OKUR Sell (S) −88 -$210 EDGAR
2025-04-08 OKUR Sell (S) −874 -$2.6K EDGAR
2025-01-29 OKUR Grant (A) — $0 EDGAR
Showing 1–10 of 26
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.